Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733091 · ClinicalTrials.gov registry record
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
A clinical trial of Tumors, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05733091 is a study of Tumors that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 300 participants, above the 184-participant average among 20 other Tumors trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05733091, a study of Tumors, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05733091
The ClinicalTrials.gov registry entry for NCT05733091 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 20 other Tumors trials with a reported enrollment target (63% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tumors appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care is the first listed.
NCT05733091 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05733091 about?
NCT05733091 is a clinical study titled "Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors". To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
What is the current status of trial NCT05733091?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2018-12-20. Estimated completion is 2029-12-31.
What conditions does trial NCT05733091 study?
This clinical trial studies the following conditions: Tumors.
What interventions are being tested in trial NCT05733091?
The interventions under investigation include: Standard of Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05733091?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05733091 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HP Pyruvate MRI in Cancers
RECRUITING · Phase 1
-
XACT ACE Observational Registry
RECRUITING
-
Perioperative Risk Study
ACTIVE NOT RECRUITING · NA
-
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
ACTIVE NOT RECRUITING · Phase 2
-
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
COMPLETED · Phase 1
-
Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.